Is Angiotensin-Converting Enzyme Inhibitor a Contraindication for Contrast-Induced Nephropathy Prophylaxis? A Review About its Paradox

Cardiovascular Therapeutics, 04/26/2012

Authors review the medical literatures and discuss the pathogenesis, the role of renin–angiotensin–aldosterone system on the development of contrast–induced nephropathy (CIN) and angiotensin–converting enzyme (ACE) inhibitors' effect on CIN.

Print Article Summary Cat 2 CME Report